Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS‐CoV‐2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL-Reference-Cited by-同舟云学术

Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS‐CoV‐2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL

Published:2024-01-24 Issue: Volume: Page:
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Campanella A.¹²^ORCID,Capasso A.¹²,Heltai S.²,Taccetti C.¹²,Albi E.²,Herishanu Y.³⁴^ORCID,Haggenburg S.⁵,Chatzikonstantinou T.⁶,Doubek M.⁷^ORCID,Kättström M.⁸,Giannopoulos K.⁹^ORCID,Simkovic M.¹⁰,Moreno C.¹¹,Massaia M.¹²¹³,Bumbea H.¹⁴¹⁵,Alshemmari S.¹⁶^ORCID,Ranghetti P.²,Perotta E.²,Martini F.²,Sant'Antonio E.²,Colia M.²,Combi C.²,Levi S.³^ORCID,Kater A. P.⁵,Hazenberg M.⁵,Nijhof I. S.⁵¹⁷,Hofsink Q.⁵,Demosthenous C.⁶¹⁸,Kotaskova J.⁷¹⁹,Zaleska J.⁹,Vrbacky F.¹⁰,Raya A. Mora¹¹,Bisogno D.¹²,Tripoli I. E.¹²¹³,Popov V. M.²⁰,Roman V.²¹,Stavroyianni N.¹⁸,Karypidou M.⁶,Scarano E.²,Locatelli M.²²,Frenquelli M.²,Scarfò L.¹²^ORCID,Stamatopoulos K.⁶,Ghia P.¹²

Affiliation:

1. Vita Salute San Raffaele University Milan Italy

2. IRCCS San Raffaele Hospital Milan Italy

3. Tel Aviv Sourasky Medical Center Tel Aviv Israel

4. Tel Aviv University Tel‐Aviv Israel

5. Amsterdam UMC Amsterdam The Netherlands

6. Centre for Research and Technology Hellas Thessaloniki Greece

7. University Hospital Brno Brno Czech Republic

8. Department of Medicine, Faculty of Medicine and Health Örebro University Örebro Sweden

9. Medical University of Lublin Lublin Poland

10. 4th Department of Internal Medicine – Haematology, Faculty of Medicine in Hradec Králové University Hospital and Charles University in Prague Hradec Kralove Czech Republic

11. Hospital de la Santa Creu I Sant Pau, Josep Carreras Leukaemia Research Institute Barcelona Spain

12. AO S.Croce e Carle Cuneo Italy

13. Turin University Turin Italy

14. University Emergency Hospital Bucharest Romania

15. University of Medicine and Pharmacy, Carol Davila Bucharest Romania

16. Department of Medicine, Faculty of Medicine Kuwait University Safat Kuwait

17. St Antonius Hospital Nieuwegein The Netherlands

18. Hematology Department and HCT Unit G. Papanicolaou Hospital Thessaloniki Greece

19. Central European Institute of Technology Masaryk University Brno Czech Republic

20. Colentina Clinical Hospital Bucharest Romania

21. Center of Immunology Department Stefan S. Nicolau Institute of Virology Bucharest Romania

22. Laboratory Medicine Service IRCCS San Raffaele Hospital Milano Italy

Funder

Fondazione Umberto Veronesi

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.27218

Reference13 articles.

1. The evolving landscape of COVID‐19 and post‐COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL

2. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia

3. Humoral response to mRNA anti–COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia

4. SARS‐CoV‐2 humoral responses following booster BNT162b2 vaccination in patients with B‐cell malignancies